Octagon Capital Advisors LP

13D and 13G Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. The latest filing for each security since 12/18/2024, newest first.

Issuer	Symbol	CUSIP	% of Class	Shares	Form	Filed
Context Therapeutics Inc. 13G/A CNTX · 21077P108	CNTX	21077P108	3.3%	3,050,000	13G/A	7/31/2026 Event 6/30/2026
Octagon Capital Advisors LP			3.3%	3,050,000
Octagon Investments Master Fund LP			3.3%	3,050,000
Ting Jia			3.3%	3,050,000
Gossamer Bio, Inc. 13G/A GOSS · 38341P102	GOSS	38341P102	3.8%	8,976,054	13G/A	5/14/2026 Event 3/31/2026
Octagon Capital Advisors LP			3.8%	8,976,054
Octagon Investments Master Fund LP			3.8%	8,976,054
Ting Jia			3.8%	8,976,054
Dianthus Therapeutics, Inc. /DE/ 13G/A DNTH · 252828108	DNTH	252828108	3.6%	1,946,667	13G/A	5/14/2026 Event 3/31/2026
Octagon Capital Advisors LP			3.6%	1,946,667
Octagon Investments Master Fund LP			3.0%	1,655,000
Octagon Biotech Opportunities Fund I LP			0.6%	291,667
Ting Jia			3.6%	1,946,667
Corbus Pharmaceuticals Holdings, Inc. 13G/A CRBP · 21833P301	CRBP	21833P301	0%	0	13G/A	5/14/2026 Event 3/31/2026
Octagon Capital Advisors LP			0%	0
Octagon Investments Master Fund LP			0%	0
Ting Jia			0%	0
Precision BioSciences, Inc. 13G DTIL · 74019P207	DTIL	74019P207	10.0%	2,328,485	13G	2/10/2026 Event 12/31/2025
Octagon Capital Advisors LP			10.0%	2,328,485
Octagon Investments Master Fund LP			10.0%	2,328,485
Ting Jia			10.0%	2,328,485
Unicycive Therapeutics, Inc. 13G/A UNCY · 90466Y202	UNCY	90466Y202	4.7%	1,000,000	13G/A	2/10/2026 Event 12/31/2025
Octagon Capital Advisors LP			4.7%	1,000,000
Octagon Investments Master Fund LP			3.0%	650,000
Octagon Biotech Opportunities Fund I LP			1.7%	350,000
Ting Jia			4.7%	1,000,000
Palisade Bio, Inc. 13G PALI · 696389402	PALI	696389402	6.4%	9,567,898	13G	2/10/2026 Event 12/31/2025
Octagon Capital Advisors LP			6.4%	9,567,898
Octagon Investments Master Fund LP			6.4%	9,567,898
Ting Jia			6.4%	9,567,898
Taysha Gene Therapies, Inc. 13G/A TSHA · 877619106	TSHA	877619106	3.3%	9,067,500	13G/A	11/14/2025 Event 9/30/2025
Octagon Capital Advisors LP			3.3%	9,067,500
Octagon Investments Master Fund			3.3%	9,067,500
Ting Jia			3.3%	9,067,500
ArriVent BioPharma, Inc. 13G/A AVBP · 04272N102	AVBP	04272N102	4.9%	1,971,054	13G/A	11/14/2025 Event 9/30/2025
Octagon Capital Advisors LP			4.9%	1,971,054
Octagon Investments Master Fund LP			1.9%	776,667
Octagon Private Opportunities Fund LP			2.0%	799,911
Octagon Special Opportunities Fund LP - Series 4			1.0%	394,476
Ting Jia			4.9%	1,971,054